ArticleBMC health services research2025
Implementation and evaluation of clinical pharmacy services in elderly outpatients with poorly controlled type 2 diabetes: a single-center experience from Vietnam.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundElderly patients with type 2 diabetes mellitus (T2DM) often face complex healthcare needs due to comorbidities and polypharmacy, increasing the risk of poor glycemic control and drug-related problems. Comprehensive Clinical Pharmacy Services (CPS) aim to optimize medication management and improve adherence, addressing these challenges effectively.
methodsThis prospective, single-center implementation study was conducted in the outpatient clinic of the Department of Endocrinology – Diabetes of a tertiary care hospital in Vietnam. Elderly patients aged ≥ 60 years with a diagnosis of T2DM for at least one year and an HbA1c level ≥ 8% were included. A trained clinical pharmacist provided a structured CPS intervention, including Medication Therapy Management (MTM) and collaborative goal-setting. The impact of pharmacy services was assessed through the number of Drug-Related Problems (DRPs) identified and resolved in prescriptions and patient medication use behaviors, improvements in HbA1C levels, as well as the satisfaction of both physicians and patients with the services provided by pharmacists.
resultsAmong 210 patients (mean age 73.5 years; 71% male), the baseline median HbA1c was 8.6% (IQR: 8.2–9.13), with 90.5% experiencing polypharmacy. A total of 231 DRPs were identified, primarily patient-related (66.2%), including unintentional misuse (28.6%) and intentional non-adherence (14.7%). DRPs related to prescribing included inappropriate drug (21.2%) and dose selection (12.6%). Of 78 pharmacist interventions, 93.5% were fully accepted or partially accepted by physicians; 100.0% were deemed clinically significant (potential Adverse Drug Event Score - pADE ≥ 0.1). Following CPS, 22.9% of patients achieved individualized HbA1c targets (p < 0.05), while the proportion of patients with HbA1c ≥ 8.5% declined from 49.2% to 32.2%. Patient and physician satisfaction with CPS was high (95.2% and 100%, respectively), though only 46.3% of patients expressed willingness to pay for services.
conclusionComprehensive CPS has a significant positive impact on quality use of medicine in elderly outpatients with T2DM. These services should be formally integrated into routine diabetes care to optimize outcomes and reduce healthcare utilization in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.